Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel S Falcão

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Ophthalmology|May 31, 2021
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic ReviewFlávio Ribeiro, Manuel S Falcão
Retina (Philadelphia, Pa.)|December 17, 2009
Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year resultsAngela M Carneiro, Manuel S Falcão, Elisete M Brandão, et al.
Case Reports in Ophthalmology|January 24, 2013
A clear cell renal cell carcinoma inhibiting the response to intravitreal antivascular endothelial growth factor therapy in wet age-related macular diseaseManuel S Falcão, João Vinagre, Paula Soares, et al.
Journal of Glaucoma|February 23, 2013
Optical coherence tomography study of peripapillary retinal nerve fiber layer and choroidal thickness in eyes with tilted optic discPedro N Brito, Marco P Vieira, Manuel S Falcão, et al.
Retina (Philadelphia, Pa.)|July 19, 2016
CHOROIDAL THICKNESS IN MULTISYSTEMIC AUTOIMMUNE DISEASES WITHOUT OPHTHALMOLOGIC MANIFESTATIONSCarla S Ferreira, João Beato, Manuel S Falcão, et al.
European Journal of Ophthalmology|April 19, 2014
Open-globe injuries at an emergency department in Porto, Portugal: clinical features and prognostic factorsSérgio M Teixeira, Ricardo R Bastos, Manuel S Falcão, et al.
Journal of Ophthalmology|June 29, 2017
Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual OutcomesAna Catarina Pedrosa, Tiago Sousa, João Pinheiro-Costa, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 9, 2014
Switch from intravitreal ranibizumab to bevacizumab for the treatment of neovascular age-related macular degeneration: clinical comparisonJoão Pinheiro-Costa, Paulo Freitas-da-Costa, Manuel S Falcão, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 14, 2012
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical settingAngela M Carneiro, Luis S Mendonça, Manuel S Falcão, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 22, 2016
Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomesAna Catarina Pedrosa, Adriana Reis-Silva, João Pinheiro-Costa, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Ophthalmology|May 31, 2021
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic ReviewFlávio Ribeiro, Manuel S Falcão
Retina (Philadelphia, Pa.)|December 17, 2009
Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year resultsAngela M Carneiro, Manuel S Falcão, Elisete M Brandão, et al.
Case Reports in Ophthalmology|January 24, 2013
A clear cell renal cell carcinoma inhibiting the response to intravitreal antivascular endothelial growth factor therapy in wet age-related macular diseaseManuel S Falcão, João Vinagre, Paula Soares, et al.
Journal of Glaucoma|February 23, 2013
Optical coherence tomography study of peripapillary retinal nerve fiber layer and choroidal thickness in eyes with tilted optic discPedro N Brito, Marco P Vieira, Manuel S Falcão, et al.
Retina (Philadelphia, Pa.)|July 19, 2016
CHOROIDAL THICKNESS IN MULTISYSTEMIC AUTOIMMUNE DISEASES WITHOUT OPHTHALMOLOGIC MANIFESTATIONSCarla S Ferreira, João Beato, Manuel S Falcão, et al.
European Journal of Ophthalmology|April 19, 2014
Open-globe injuries at an emergency department in Porto, Portugal: clinical features and prognostic factorsSérgio M Teixeira, Ricardo R Bastos, Manuel S Falcão, et al.
Journal of Ophthalmology|June 29, 2017
Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual OutcomesAna Catarina Pedrosa, Tiago Sousa, João Pinheiro-Costa, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 9, 2014
Switch from intravitreal ranibizumab to bevacizumab for the treatment of neovascular age-related macular degeneration: clinical comparisonJoão Pinheiro-Costa, Paulo Freitas-da-Costa, Manuel S Falcão, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 14, 2012
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical settingAngela M Carneiro, Luis S Mendonça, Manuel S Falcão, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 22, 2016
Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomesAna Catarina Pedrosa, Adriana Reis-Silva, João Pinheiro-Costa, et al.
Pageof 2